You've dedicated years to a biotech company, pouring your energy into the mission. Your hard work has been rewarded with a compensation package rich in restricted stock units (RSUs), stock options, and other forms of equity. On paper, you're doing well. But in the unpredictable world of biotech, a single FDA announcement, a missed trial endpoint, or a broader market downturn can send your stock price plummeting.
Suddenly, your paper wealth feels out of reach. You might have millions in equity, but you need $100,000 for a college tuition payment or a down payment on a new home and you need it now. Cashing out your shares at a low point means locking in losses, something every savvy executive wants to avoid.
This is a common and emotionally charged dilemma for leaders in volatile or pre-revenue companies. So, what are your options when you're equity-rich but liquidity-thin?
Option 1: The Securities-Based Line of Credit (SBLOC)
One of the most powerful tools in this situation is a securities-based line of credit (SBLOC). This allows you to leverage your publicly traded shares, or even late-stage private equity with secondary liquidity programs, as collateral. Major lenders like UBS, Morgan Stanley, and JPMorgan offer these lines of credit, often at a low-interest rate.
The Biotech Advantage: A key benefit is that an SBLOC does not require you to sell your stock, meaning you avoid a taxable event and keep your long-term upside intact. Additionally, an SBLOC may be accessible even during a company blackout window, allowing you to secure needed funds without violating insider trading restrictions. The primary risk is a margin call if the stock's value falls further, which could force a sale.
It's important to understand that there are potential ramifications of doing a SBLOC. The stock price could fall below a certain percentage where the lending institution will still require you to sell the securities to pay the loan back or bring the value back to a certain level. There are also tax ramifications, so make sure to speak with a tax professional to fully understand the risks before making any decision.
Option 2: Tapping Into Your Retirement Accounts
For short-term funding gaps, your retirement accounts can offer a solution without forcing a stock sale.
· Roth IRA Contributions: You can withdraw your direct contributions (not the earnings) from a Roth IRA at any time, penalty- and tax-free.
· 401(k) Loan: You may be able to borrow up to $50,000 from your 401(k) plan. You pay yourself back with interest, and the loan does not trigger a taxable event as long as it is repaid according to the terms.
These options provide a quick and efficient way to bridge a temporary cash need without impacting your company equity. But remember, by choosing this option, you have a lost opportunity risk in your retirement accounts and still may be forced to sell the securities to cover.
Option 3: Planning with Upcoming Liquidity Events
Look to your compensation calendar for upcoming liquidity events that may align with your cash needs.
· ESPP Payouts: Time a sale of shares from an Employee Stock Purchase Plan (ESPP) to coincide with your expense.
· Bonus Payouts: Use an annual or performance bonus.
· RSU Vesting: Plan a sale of newly vested RSUs at the end of the year.
If you have a relationship with your HR or compensation planning team, you may even be able to discuss options for timing a partial deferral or a split vest for tax reasons to better manage cash flow.
Option 4: Delay or Defer the Expense
Sometimes, the best strategy is to address the expense itself. Not all spending has to happen immediately. Could you work with a financial planner to:
· Spread Out Funding: Look at ways to phase an expense, such as a large tuition bill, over time.
· Creative Financing: Explore alternative financing options for a down payment or legal settlement.
· Refinance: Consider refinancing an existing debt to free up cash flow.
Prepare for the Next Downturn (Now)
The emotional rollercoaster of an ill-timed cash need is an experience you don't want to repeat. Now is the time to prepare for the next downturn.
· Build a Liquidity Buffer: Establish a cash reserve of six to twelve months of living expenses, separate from your investment portfolio.
· Create a Planned Sale Schedule: Work with a CFP and a CPA to create a tax-aware, pre-determined RSU sale schedule at higher stock levels. This removes emotion from the decision-making process, ensuring you regularly rebalance your portfolio and reduce over-concentration.
· Implement a Diversification Plan: Proactively convert a portion of your equity into a diversified portfolio.
If your net worth is heavily tied to biotech equity, planning ahead can be the difference between reacting in panic or moving with confidence. Schedule a review to explore options that preserve your long-term upside, even when your stock is temporarily down.
There are tax consequences to cashing in RSUs. You should always work with a tax professional to determine all risks and consequences to any actions you may take.
Disclaimer: Neither MML Investors Services nor any of its subsidiaries, employees or agents are authorized to give legal or tax advice. Consult your own personal attorney, legal or tax counsel for advice on specific legal and tax matters.
CRN202807-9245170